zuma-7: axi-cel in r/r large b-cell lymphoma
Published 2 years ago • 547 plays • Length 6:37Download video MP4
Download video MP3
Similar videos
-
2:55
updates from zuma-7: axi-cel for r/r dlbcl
-
1:15
primary overall survival analysis of the zuma-7 trial
-
1:08
zuma-7: overall survival benefit of axi-cel over soc in second-line lbcl
-
4:44
zuma-7 subgroup analysis: axi-cel vs soc in elderly patients with r/r lbcl
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
2:19
zuma-3: identifying the optimal dose of axi-cel in r/r all
-
32:56
echo analyzer monthly maintenance
-
44:37
webinar: how close are we to curing follicular lymphoma?
-
26:31
survival analysis overview
-
1:20
axi-cel in patients with r/r lbcl in complete metabolic response
-
2:43
long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
-
1:34
zuma-1 update: safety data of axi-cel in patients with r/r dlbcl
-
0:54
insights into the zuma-23 trial: axi-cel in frontline high-risk lbcl
-
1:39
updates on zuma-7: clinical and patient-reported outcomes in elderly patients with r/r lbcl
-
0:54
zuma-3 end of phase i results: axi-cel for r/r all
-
2:06
zuma-12: axi-cel as first-line therapy in high-risk large b-cell lymphoma
-
1:21
approval of axi-cel in second-line for r/r lbcl & label update
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
3:10
zuma-9: expanded access protocol and oos axicabtagene ciloleucel in r/r dlbcl
-
1:54
brexu-cel in the treatment of r/r mcl: insights from the zuma-2 and zuma-18 trials
-
2:52
zuma-24 preliminary analysis of axi-cel in the outpatient setting in patients with r/r lbcl
-
2:59
axi-cel in older patients: data from zuma-1 and clinical use